Intimacy-Enhancing Couples' Intervention for Localized Prostate Cancer
NCT01982058 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 483
Last updated 2022-10-19
Summary
RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners.
PURPOSE: This randomized clinical trial is studying how well therapy enhances communication and intimacy for men with early stage prostate cancer and for their partners.
Conditions
- Prostate Cancer
- Sexual Dysfunction and Infertility
- Sexuality
Interventions
- OTHER
-
communication intervention
- OTHER
-
counseling intervention
- OTHER
-
nutrition intervention
- OTHER
-
questionnaire administration
Sponsors & Collaborators
-
Rutgers Cancer Institute of New Jersey
collaborator OTHER -
Memorial Sloan Kettering Cancer Center
collaborator OTHER -
Fox Chase Cancer Center
collaborator OTHER -
Rutgers, The State University of New Jersey
lead OTHER
Principal Investigators
-
Sharon L Manne, Ph.D. · Rutgers Cancer Institute of New Jersey
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-08-18
- Primary Completion
- 2017-08-07
- Completion
- 2017-08-07
Countries
- United States
Study Locations
More Related Trials
-
Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer
NCT00769548 ·Status: COMPLETED ·Phase: PHASE3
-
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African Americans
NCT04215029 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Longitudinal Assessment of Health-Related Quality of Life in Men With Localized Prostate Cancer
NCT00582842 ·Status: COMPLETED
-
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT03678025 ·Status: RECRUITING ·Phase: PHASE3
-
Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer
NCT02008058 ·Status: COMPLETED
-
Treatment Preference and Patient Centered Prostate Cancer Care
NCT02032550 ·Status: COMPLETED ·Phase: NA
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
NCT03860987 ·Status: COMPLETED ·Phase: PHASE2
-
Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation
NCT05790213 ·Status: RECRUITING ·Phase: PHASE2
-
A Journey Into Participation Patterns Among Metastatic Prostate Cancer Patients
NCT06009549 ·Status: NOT_YET_RECRUITING
-
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
NCT00936390 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Controlled Trial to Promote Physician-Patient Discussion of Prostate Cancer Screening
NCT00208988 ·Status: COMPLETED ·Phase: NA
-
Treatment Decision Analysis Model for Prostate Cancer: A Randomized Trial
NCT02024685 ·Status: TERMINATED ·Phase: NA
-
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
NCT03939689 ·Status: COMPLETED ·Phase: PHASE2
-
Addressing Health Literacy With a Tailored Survivorship Care Plan
NCT06674863 ·Status: RECRUITING ·Phase: NA
-
Flibanserin in Men Receiving Androgen Suppression for Prostate Cancer
NCT04743934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management Program
NCT04350788 ·Status: COMPLETED ·Phase: NA
-
Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer
NCT00170157 ·Status: COMPLETED ·Phase: PHASE2
-
Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
NCT00006359 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-Up Study for Men Diagnosed With Prostate Cancer Through Participation in a Prostate Specific Antigen Screening Program
NCT00035217 ·Status: COMPLETED
-
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
NCT00298155 ·Status: COMPLETED ·Phase: PHASE2
-
Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer
NCT03016741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations
NCT03835533 ·Status: COMPLETED ·Phase: PHASE1
-
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their Partners
NCT03575832 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
NCT00002597 ·Status: COMPLETED ·Phase: PHASE3